findmyKOL
Clinical trialNCT02817906TerminatedPhase 3Interventional

ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease

SponsorIntra-Cellular Therapies, Inc.Enrollment177Agitation in Dementia, Including Alzheimer's Disease
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Facility name not stated

    Sun City, Arizona, United States

  • Facility name not stated

    Little Rock, Arkansas, United States

  • Facility name not stated

    Rogers, Arkansas, United States

  • Facility name not stated

    Costa Mesa, California, United States

  • Facility name not stated

    Glendale, California, United States

  • Facility name not stated

    Irvine, California, United States

  • Facility name not stated

    Lemon Grove, California, United States

  • Facility name not stated

    Long Beach, California, United States

  • Facility name not stated

    Oceanside, California, United States

  • Facility name not stated

    Riverside, California, United States

  • Facility name not stated

    Santa Ana, California, United States

  • Facility name not stated

    Hallandale, Florida, United States

  • Facility name not stated

    Hialeah, Florida, United States

  • Facility name not stated

    Miami, Florida, United States

  • Facility name not stated

    Orlando, Florida, United States

  • Facility name not stated

    Suwanee, Georgia, United States

  • Facility name not stated

    Honolulu, Hawaii, United States

  • Facility name not stated

    Las Vegas, Nevada, United States

  • Facility name not stated

    Berlin, New Jersey, United States

  • Facility name not stated

    Marlton, New Jersey, United States

  • Facility name not stated

    Toms River, New Jersey, United States

  • Facility name not stated

    Brooklyn, New York, United States

  • Facility name not stated

    Staten Island, New York, United States

  • Facility name not stated

    Centerville, Ohio, United States

  • Facility name not stated

    Dayton, Ohio, United States

  • Facility name not stated

    San Antonio, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Aug 2016
Primary completion
30 Jan 2019
Completion
30 Jan 2019
Last update posted
29 Jun 2021
Registered enrollment
177
Registry id
NCT02817906

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.